Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-27 @ 11:46 PM
Study NCT ID:
NCT00705250
Status:
COMPLETED
Last Update Posted:
2017-03-03
First Post:
2008-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-24
First Submit QC Date:
None
Study First Post Date:
2008-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-21
Results First Submit QC Date:
None
Results First Post Date:
2017-01-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-18
Last Update Post Date:
2017-03-03
Last Update Post Date Type:
ACTUAL